Yasmeen Rahimi

Jul 13, 2026

Yasmeen Rahimi rated EQ as Overweight on Jul 13, 2026, setting a price target of 20. Shares have remained stable near 2.88, leaving the 20 target still in play.

Jun 12, 2026

On Jun 12, 2026, TENX was given a Overweight rating by Yasmeen Rahimi, with a target price of 50. The stock rallied 39.20% after the rating, narrowing the gap to the target of 50 and validating the bullish stance.

May 20, 2026

DRUG received a Overweight rating from Yasmeen Rahimi on May 20, 2026, aiming for 220. The rating hasn’t played out as hoped, with the stock trading 8.27% below expectations.

May 11, 2026

On May 11, 2026, Yasmeen Rahimi published a Overweight outlook on AVTX, with a target of 60. Market action contradicted the Buy thesis, as shares slipped to 18.91.

May 08, 2026

Yasmeen Rahimi on May 08, 2026 assigned NKTR a Overweight rating, with a price target of 192. The call has struggled to gain traction, with shares losing 16.57%.

May 04, 2026

On May 04, 2026, Yasmeen Rahimi reaffirmed ANAB with a Overweight rating, targeting 93. Market indecision has kept the 93 target in a holding pattern.

Apr 16, 2026

ROIV was rated Overweight by Yasmeen Rahimi on Apr 16, 2026, with a price objective of 40. A bullish response from the market helped close the gap of 5.49 to the target.

Mar 12, 2026

Yasmeen Rahimi issued a Overweight recommendation for PLRX on Mar 12, 2026, price target set at 4. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Mar 04, 2026

On Mar 04, 2026, ARCT was evaluated by Yasmeen Rahimi, who gave a Overweight rating and target of 72. So far, the Buy call awaits clearer momentum, with shares flat at 6.71.

Feb 13, 2026

Yasmeen Rahimi rated CLYM as Overweight on Feb 13, 2026, setting a price target of 23. The call has proven timely, with shares rising 132.98% toward the price target of 23.

Jan 29, 2026

On Jan 29, 2026, KRRO was given a Overweight rating by Yasmeen Rahimi, with a target price of 30. The stock traded sideways with a 1.43% move, keeping the bullish thesis unresolved.

Jan 28, 2026

STTK received a Overweight rating from Yasmeen Rahimi on Jan 28, 2026, aiming for 15. Momentum has favored the Buy call, with shares climbing from 6.43 to 6.43, rewarding those who trusted the recommendation.

Jan 28, 2026

On Jan 28, 2026, Yasmeen Rahimi published a Overweight outlook on PRAX, with a target of 1200. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 314.56.

Jan 27, 2026

Yasmeen Rahimi on Jan 27, 2026 assigned BIOA a Overweight rating, with a price target of 73. The Buy call aligned well with market performance, producing a gain of 11.15%.

Dec 29, 2025

On Dec 29, 2025, Yasmeen Rahimi reaffirmed PALI with a Overweight rating, targeting 25. Shares slid 23.79% despite the recommendation, highlighting downside risks.

Dec 19, 2025

MDGL was rated Overweight by Yasmeen Rahimi on Dec 19, 2025, with a price objective of 900. This case shows how bullish projections can fail, with the stock now below 531.

Dec 18, 2025

On Dec 18, 2025, Yasmeen Rahimi initiated coverage on ORKA with a Overweight rating and target of 75. Neutral price movement of % leaves room for interpretation.

Oct 28, 2025

Yasmeen Rahimi issued a Overweight recommendation for PRTA on Oct 28, 2025, price target set at 36. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Oct 06, 2025

On Oct 06, 2025, LBRX was evaluated by Yasmeen Rahimi, who gave a Overweight rating and target of 78. This case illustrates how a timely bullish rating can translate into tangible gains of 113.01%.

Aug 27, 2025

On Aug 27, 2025, IVA was given a Overweight rating by Yasmeen Rahimi, with a target price of 26. Despite the Buy call, shares fell from 4.3 to 4.3, challenging the optimistic stance.

Jun 23, 2025

VRNA received a Overweight rating from Yasmeen Rahimi on Jun 23, 2025, aiming for 160. Momentum has favored the Buy call, with shares climbing from 106.91 to 106.91, rewarding those who trusted the recommendation.

Apr 02, 2025

On Apr 02, 2025, Yasmeen Rahimi published a Overweight outlook on EWTX, with a target of 51. Shares gained 165.91%, underscoring the accuracy of the bullish outlook toward 51.

Mar 07, 2025

Yasmeen Rahimi on Mar 07, 2025 assigned LXRX a Overweight rating, with a price target of 6. The Buy call aligned well with market performance, producing a gain of 453.85%.

Sep 23, 2024

On Sep 23, 2024, Yasmeen Rahimi reaffirmed NAMS with a Overweight rating, targeting 37. The recommendation was supported by strong follow-through as the stock rose from 33.28 to 33.28.

Sep 19, 2024

ZURA was rated Overweight by Yasmeen Rahimi on Sep 19, 2024, with a price objective of 26. A bullish response from the market helped close the gap of 20.85 to the target.

Aug 14, 2024

On Aug 14, 2024, Yasmeen Rahimi initiated coverage on SLRN with a Overweight rating and target of 20. The Buy call has yet to be validated as shares remain 17.73 away from the target.

Jul 16, 2024

Yasmeen Rahimi issued a Overweight recommendation for IMUX on Jul 16, 2024, price target set at 28. The target of 28 remains in play, though confirmation will depend on future moves.

Jul 02, 2024

On Jul 02, 2024, CRNX was evaluated by Yasmeen Rahimi, who gave a Overweight rating and target of 97. This case illustrates how a timely bullish rating can translate into tangible gains of 83.73%.

Jun 21, 2024

Yasmeen Rahimi rated ALT as Overweight on Jun 21, 2024, setting a price target of 25. The stock has underperformed, dropping 53.35% despite the bullish target of 25.

Jun 13, 2024

On Jun 13, 2024, BNTC was given a Overweight rating by Yasmeen Rahimi, with a target price of 30. The stock rallied 73.66% after the rating, narrowing the gap to the target of 30 and validating the bullish stance.

May 07, 2024

DSGN received a Overweight rating from Yasmeen Rahimi on May 07, 2024, aiming for 12. Momentum has favored the Buy call, with shares climbing from 13.855 to 13.855, rewarding those who trusted the recommendation.